Future opportunities of the Gynecological Cancer Intergroup.
The Gynecologic Cancer Intergroup (GCIG) is an international collaboration of cooperative clinical trials groups who conduct randomized phase III clinical trials in the population of women affected by gynecologic cancer. This collaboration amongst 18 member groups allows for rapid accrual of women to such trials with outcomes that are rapidly generated and readily generalizable to a broad population. Future considerations should include studies in prevention and translational research through improved processes and new global partnerships.
Stuart
G C E
GC
Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. gstuart@medd.med.ubc.ca
D002986:Clinical Trials as Topic / Q000639:trends*; D005260:Female; D005833:Genital Neoplasms, Female; D006801:Humans